VKTX241101P58000
- 0.05
- 0.000.00%
Viking Therapeutics Newsroom
Unpacking the Latest Options Trading Trends in Viking Therapeutics
StoneTree Investment Partners Invests in Viking Engineering
"Weight loss drug investment frenzy" once again sweeps the stock market. Novo Nordisk (NVO.US) may overshadow eli lilly and co (LLY.US).
The stock price of this Danish company has fallen by more than 25% from its highest point; analysts believe novo-nordisk a/s has performed outstandingly in trial data and factory expansion.
Viking Therapeutics(VKTX.US) Officer Sells US$10.09 Million in Common Stock
Form 144 | Viking Therapeutics(VKTX.US) Officer Proposes to Sell 10.28 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 28, $Viking Therapeutics(VKTX.US)$ Officer GREG ZANTE intends to sell 131.69K shares of its common stock on Oct 28, with a total market value of approximately $10.28
Viking Therapeutics to Highlight Clinical Data From VK2735 Obesity Program in Presentations at ObesityWeek 2024
Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing
Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $120
Viking Therapeutics Options Spot-On: On October 25th, 90,685 Contracts Were Traded, With 218.76K Open Interest
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $125
"Weight loss drug newcomer" Viking (VKTX.US) Q3 performance exceeds expectations, VK2735 prospects are unanimously bullish on Wall Street.
viking therapeutics surged on Thursday, as Wall Street has high hopes for its obesity candidate drug VK2735 latest developments, and the company also announced better-than-expected financial data for the third quarter.
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday
Market Climbs Following Tesla Earnings Beat | Wall Street Today
Viking Therapeutics Options Spot-On: On October 24th, 105.23K Contracts Were Traded, With 200.08K Open Interest
Viking Therapeutics Shares Rise 20.70% Following Q3 Results
Sector Update: Health Care Stocks Decline Thursday Afternoon
3 Health Care Stocks Moving In Thursday's Intraday Session
Q3 2024 Viking Therapeutics Inc Earnings Call